T1	Treatment 58 119	antioxidant supplements and anti-helicobacter pylori therapy.
T2	Treatment 581 730	to receive anti-Helicobacter pylori triple therapy and/or dietary supplementation with ascorbic acid, beta-carotene, or their corresponding placebos.
T3	Treatment 731 817	Gastric biopsy specimens taken at baseline were compared with those taken at 72 months
T4	Treatment 1315 1332	for beta-carotene
T5	Treatment 1372 1389	for ascorbic acid
